Advertisement

How can Plegridy help treat people with relapsing-remitting MS?

Plegridy, a new interferon product, has received U.S. Food and Drug Administration (FDA) approval as a treatment for relapsing forms of multiple sclerosis (MS). In a clinical trial, Plegridy was shown to significantly reduce important clinical and imaging measures, including slowing the progression of disability and decreasing the number of relapses and brain lesions. Plegridy is given by subcutaneous injection every two weeks. 

Continue Learning about Multiple Sclerosis Treatment

Can Alternative Therapies Help Manage Multiple Sclerosis?
Can Alternative Therapies Help Manage Multiple Sclerosis?
Many MS patients are looking for an extra advantage in managing symptoms or slowing disease progression. Watch neurologist Charles Smith, MD, explain ...
Read More
What are different categories of alternative treatments for MS?
Louis RosnerLouis Rosner
Categories of alternative treatments:Treatments that increase blood flowTreatments that decrease blo...
More Answers
Is vertebral artery surgery effective for treating MS?
Louis RosnerLouis Rosner
In the 1970s, a Los Angeles vascular surgeon reported that his multiple sclerosis (MS) patients show...
More Answers
What Is the Focus of Research for Multiple Sclerosis?
What Is the Focus of Research for Multiple Sclerosis?

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.